期刊文献+

不同血液净化方式治疗不安腿综合征的疗效观察 被引量:2

Clinical observation of curative effects of different blood purification methods on restless legs syndrome
下载PDF
导出
摘要 目的观察血液灌流(HP)串联血液透析(HD)治疗不安腿综合征的临床疗效,探讨不同血液净化方式治疗不安腿综合征的优越性。方法将26例有不安腿综合征的长期维持血液透析的病人随机分为治疗组(13例)和对照组(13例),对照组常规行血液透析治疗,治疗组行血液灌流串联血液透析(HP+HD)治疗(1次/w),连续2个月。观察2组治疗2个月前后临床表现及血清甲状旁腺激素(PTH)浓度变化。结果治疗组总有效率84.62%,治疗后PTH浓度明显下降(P<0.01)。对照组治疗后临床症状及PTH均无明显变化,总有效率23.07%,低于治疗组的总有效率(P<0.01)。结论 HP+HD治疗不安腿综合征明显优于单独使用HD治疗。 Objective To observe the clinical effects of hemoperfusion(HP) combined with hemodialysis(HD) on restless leg syndrome,and discuss the advantages of different blood purification methods for this syndrome.Methods 26 patients with restless leg syndrome and receiving long-term maintenance-hemodialysis were randomly divided into treatment group(13 cases) and control group(13 cases).The control group only received HD,while the treatment group received HP combined with HD once a week for two successive months.Changes of clinical manifestation and concentration of serum parathyroid hormone(PTH) of the two groups were observed before and after the treatment.Results The total effective rate of the treatment group was 84.62%.After the treatment,the concentration of PTH decreased significantly(P〈0.01).The total effective rate of the control group was 23.07%,which was lower than that of the treatment group(P〈0.01).There were no obvious changes of the clinical manifestation and PTH in the control group after the treatment.Conclusion The curative effect of HP combined with HD for restless leg syndrome is obviously better than that of HD alone.
出处 《西南国防医药》 CAS 2011年第9期953-955,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 尿毒症 不安腿综合征 血液灌流 血液透析 疗效 uraemia restless legs syndrome hemoperfusion hemodialysis curative effect
  • 相关文献

参考文献6

二级参考文献46

  • 1汤晓芙,卢祖能.内科疾病合并周围神经病[J].临床神经病学杂志,1996,9(2):121-123. 被引量:4
  • 2汤晓芙.神经系统临床电生理学(肌电图学及其他)[M].化京:人民军医出版社,2002.289.
  • 3[1]Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immo bileized fiber column in patients with systemic inflammatory rssponse syndrome: The Japanese Experiense, Therapeutic Apheresis and Dialysis,2003,7(2) :252 - 258
  • 4[2]Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin). Therapeutic Apheresis and Dialysis, 2003,7(1):108 - 114
  • 5[3]Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross- over comparison of three LDL - apheresis system in stain pretreated patients with familial hypercholesterolaemia. Athernsclerosis,2000,151(2) :493 - 7
  • 6[4]Ritter M. M, Parhofer K.G. Extracorporal low - density lipoprotein by innunoadsorption. Therapeutic Apheresis and Dialysis, 2003, 7 ( 3 ):370 - 372
  • 7[5]Nakaji S, Haynshi N. Adsorption for myasthenia gravis treatment:Medisorba MG - 50. Therapeutic Apheresis and dialysis, 2003,7 ( 1 ):78 - 84
  • 8[6]Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Therapeutic Apheresis and Dialysis, 2003,7( 1 ) :85 - 90
  • 9[7]Bambauer R,Schiel R, Latza R,et al. LDL apheresis in clinical practice: long - term treatment of severe hyperlipidemia. Ther Apher, 1997,1(1): 49-51
  • 10[8]Brunton C, Varghese Z, Moorhead F. Lipoheresis in the nephrotic syndrome. kidney Int,1999,56(Suppl 71) :s6- s8

共引文献62

同被引文献14

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部